LEUPRORELINE Sandoz 1 mois implant 3.6 mg ser pré
7680574490020
CH-57449
L02AE02
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat
Fertigspritze
1 x 1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
leuprorelinum
|
3.6 MG | Substance | Wirkstoff (Principe actif) |
|
leuprorelini acetas
|
- | Substance | WIZUS |
|
poly(lactidum-co-glycolidum)
|
- | Substance | HNIDK |
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 57449
- Drug name
- Leuprorelin Sandoz 1 Monat, Fertigspritze mit Implantat
- Galenic form
- IMPF
- ATC Code
- L02AE02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- A
- First authorization
- 04/06/2008
- Authorization expiration date
- 31/05/2026
- IT number
- 07.16.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LEUPRORELINE Sandoz 1 mois implant 3.6 mg ser pré
- Description (DE)
- LEUPRORELIN Sandoz 1 Monat Implant 3.6 mg Fertspr
- Market launch
- 04/06/2008
- Market withdrawal
- 31/05/2026
- Narcotic (BTM)
- No